|

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

RECRUITINGSponsored by Western Sydney Local Health District
Actively Recruiting
SponsorWestern Sydney Local Health District
Started2023-03-14
Est. completion2028-03-14
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05804331

Summary

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* UGI neoplastic lesions \> 10mm

  * Lesions for ESD limited to the mucosal and/or submucosal layer OR
  * Lesions for EFTR limited to the muscularis propria layer OR
  * Lesions for STER limited to the submucosal and/or muscularis propria layer
* Aged 18 years or older

Exclusion Criteria:

* Age less than 18
* Unable to give informed consent
* Pregnant or lactating patients
* Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally

Conditions10

CancerCancer of StomachEsophageal NeoplasmsGI CancerGISTGastric AdenocarcinomaGastric CancerGastric NeoplasmNeuroendocrine TumorsOesophageal Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.